Crystallization and preliminary X-ray crystallographic analysis of SEDL by Jang, SB et al.
564 Jang et al.  SEDL Acta Cryst. (2002). D58, 564±566
crystallization papers
Acta Crystallographica Section D
Biological
Crystallography
ISSN 0907-4449
Crystallization and preliminary X-ray
crystallographic analysis of SEDL
Se Bok Jang,a Yong-Soon Cho,a
Soo-Jung Eom,b Eui-Ju Choi,b
Kyung-Hwa Kim,c Pann-Ghill
Suha and Byung-Ha Oha,c*
aNational Creative Research Initiative Center for
Biomolecular Recognition and Department of
Life Science, Pohang University of Science and
Technology, Pohang, Kyungbuk 790-784, South
Korea, bNational Creative Research Initiative
Center for Cell Death, Graduate School of
Biotechnology, Korea University,
Seoul 136-701, South Korea, and cPohang
Accelerator Laboratory, Pohang,
Kyungbuk 790-784, South Korea
Correspondence e-mail: bhoh@postech.ac.kr
# 2002 International Union of Crystallography
Printed in Denmark ± all rights reserved
SEDL (known also as sedlin) is a 140 amino-acid protein with a
putative role in endoplasmic reticulum-to-Golgi transport. Several
missense mutations and deletion mutations in the SEDL gene, which
result in protein truncation by frame shift, are responsible for
spondyloepiphyseal dysplasia tarda, a progressive skeletal disorder.
The protein is identical to MIP-2A, which was shown to interact
physically with c-myc promotor-binding protein 1 (MBP-1) and
relieve the regulatory role of MBP-1 as a general transcription
repressor. In order to gain insights into the function of SEDL by
structural analysis, the protein was overexpressed and crystallized as
a ®rst step. SEDL was overexpressed in Escherichia coli and
crystallized using the hanging-drop vapour-diffusion method at
298 K. The crystals belong to the orthorhombic space group C2221,
with unit-cell parameters a = 46.69, b = 101.30, c = 66.15 AÊ . The unit
cell is likely to contain one molecule of SEDL, with a crystal volume
per protein mass (VM) of 2.36 AÊ
3 Daÿ1 and a solvent content of about
47.9% by volume. A native data set to 2.8 AÊ resolution was obtained
from a ¯ash-cooled crystal using synchrotron radiation.
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1. Introduction
X-linked spondyloepiphyseal dysplasia tarda
(SEDT) is a genetic disease characterized by
disproportionately short trunk, short stature
and an absence of systemic complications
(Bannerman et al., 1971; MacKenzie et al.,
1996). SEDT is caused by the production of a
probably non-functional form of SEDL caused
by mutations in the SEDL gene located at
human chromosome Xp22 (Gedeon et al.,
1999). Analysis of a spectrum of SEDL muta-
tions in unrelated cases of SEDT ascertained
from different ethnic populations showed that
frameshift mutations leading to a premature
termination of translation account for >43% of
SEDT cases, with half of these arising from
dinucleotide deletions (Gedeon et al., 2001).
An analysis of a Japanese family showed that
such a deletion mutation was present in a
proband (diagnosed as having SEDT) and his
unaffected mother (a heterozygote), but not in
an unaffected sister and an unaffected uncle
(Matsui et al., 2001), indicating that loss of
SEDL caused SEDT. A total of seven SEDL
pseudogenes were detected in the human
genome. Among these, SEDLP1, a transcribed
retropseudogene on chromosome 19, encodes
a protein identical to that of the SEDL gene on
chromosome Xp22 as described below (Gecz et
al., 2000). It is not yet clear whether a
compensatory effect of SEDLP1 may contri-
bute to the absence of a phenotypic effect in
most tissues that are under control of a
different promoter (Gedeon et al., 1999).
SEDL appears to be an evolutionary
conserved protein, as its homologues have
been identi®ed in yeast, Drosophila melano-
gaster, Caenorhabditis elegans, mouse and rat
(Gedeon et al., 1999). The yeast SEDL homo-
logue (ORF YBR254C or p20) was recently
characterized as a member of a transport
protein particle known as TRAPP (Sacher &
Ferro-Novick, 2001), which is a large protein
complex required in the endoplasmic reti-
culum-to-Golgi vesicle transport (Lowe, 2000).
The yeast gene was shown to be an essential
gene by tetrad analysis following sporulation of
heterozygous disruptants (Sanjuan et al., 1999).
A protein identical to SEDL was found to
physically interact with and antagonize the
functional activity of c-myc promotor-binding
protein 1 (MBP-1; Ghosh et al., 2001),
which transcriptionally down-regulates c-myc
promotor activity by directly binding to the
c-myc P2 promotor sequence (Ray & Miller,
1991). The protein was named MBP-1 inter-
acting protein (MIP-2A) because of the
observation of a direct interaction between the
two in a yeast two-hybrid analysis and in an
in vitro glutathione S-transferase pull-down
experiment (Ghosh et al., 2001). Functional
analysis indicates that MIP-2A relieves the
transcriptional repression of MBP-1 and
antagonizes MBP-1-mediated cell death in
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®broblasts (Ghosh et al., 2001). Although
the coding sequences of the MIP-2A and
SEDL genes are identical, their untranslated
regions are signi®cantly different and the
MIP-2A gene (described above as SEDLP1)
is located at human chromosome 19, while
the SEDL gene is located at chromosome
Xp22. Further characterization of MIP-2A/
SEDLP1, SEDL and SEDL pseudogenes
are necessary in order to understand the
functional relationships between these
genes.
A database search for sequence homology
with SEDL does not yield any protein whose
biochemical function or three-dimensional
structure is known. Structural information
on SEDL could lead to the identi®cation of
the biochemical function of the protein. The
structure of SEDL could serve as a stepping
stone for probing its seemingly completely
different roles in antagonizing MBP-1 and
for deciphering the potential complexity of
the biochemical roles of SEDL. In this
report, we describe preliminary X-ray crys-
tallographic analyses of mouse SEDL, which
differs from human SEDL by the presence
of seven conservative mutations out of a
total of 140 amino acids.
2. Protein expression and purification
The SEDL gene was ampli®ed by the poly-
merase chain reaction (PCR) technique
from a mouse cDNA library. The PCR
products were puri®ed, digested with XhoI
and BlpI and then ligated into the pET15b
vector (Novagen). The resulting vector was
introduced into Escherichia coli BL21
(DE3) RIL strain. The vector construction
resulted in SEDL fused to a His6 tag at the
N-terminus. The expression of the recombi-
nant SEDL protein was induced by 1 mM
isopropyl-d-thiogalactopyranoside at an
optical density of 0.5±0.6 at 298 K for 8 h.
Bacterial lysates were prepared by sonica-
tion in buffer A (50 mM Tris±HCl pH 7.6
and 200 mM NaCl).
SEDL was obtained after cleavage by
thrombin. The His6-tagged fusion protein
bound to an Ni±NTA column (Qiagen) was
eluted with buffer A containing 200 mM
imidazole after washing the column with the
same buffer. The eluted fractions were
dialyzed against buffer A and reacted with
thrombin (Roche Molecular Biomedicals) at
a fusion protein:thrombin weight ratio of
20:1 for 12 h at 277 K. The reaction mixture
was loaded onto an Ni±NTA column and
unbound fractions were collected. The frac-
tions were concentrated to 0.5 mg mlÿ1 and
loaded onto a Resource Q anion-exchange
column (Amersham-Pharmacia) pre-equili-
brated with buffer A. Unbound fractions
were collected and concentrated and subse-
quently loaded onto a Superdex 75 column
(Amercham-Pharmacia) pre-equilibrated
with a buffer composed of 50 mgM Tris±
HCl pH 7.6 and 250 mM NaCl. The
protein solution was concentrated to about
10 mg mlÿ1 using a Vivaspin 20 (Satorius).
The puri®ed SEDL was at least 95% pure as
judged on a polyacrylamide gel.
3. Crystallization of SEDL
Crystals of SEDL were obtained by the
hanging-drop vapour-diffusion method at
298 K using 24-well Linbro plates (Hampton
Research). A hanging drop was prepared by
mixing equal volumes (1.5 ml each) of the
protein solution and the reservoir solution.
Each hanging drop was placed over 0.5 ml of
reservoir solution. The ®rst crystallization
screening was performed with Crystal
Screen (Hampton Research), a sparse-
matrix screening kit (Jancarik & Kim, 1991).
SEDL crystallized as clusters of micro-
crystals with a precipitant containing 1.4 M
sodium acetate and 0.1 M sodium cacodylate
pH 6.5. Under these conditions, crystals
appeared after 3±7 d and grew to a
maximum size within two weeks. Microseed
crystals were transferred to a 1:1 mixture of
the same protein sample and a precipitant
containing 1.0 M sodium acetate, 0.1 M
sodium cacodylate pH 6.5 and 5±10%
glycerol to obtain larger crystals; crystals
were touched on the surface using the tip of
a human hair. The crystals thus obtained
were larger than the original ones, but still
were small thin plates with a largest dimen-
sion of approximately 0.1 mm (Fig. 1).
4. Data collection and analysis
Diffraction data were collected from a ¯ash-
cooled crystal at 100 K using synchrotron
radiation from beamline 6B at Pohang
Accelerator Laboratory, Korea. Before data
collection, the crystal was soaked brie¯y in a
cryoprotectant solution which was the
precipitant solution containing 15%
glycerol. Diffraction data (Table 1) were
obtained and processed using the programs
DENZO and SCALEPACK (Otwinowski &
Minor, 1997). The native diffraction data
were collected to 2.8 AÊ . The crystals belong
to the orthorhombic space group C2221. We
calculated that the crystal volume per
molecular weight (VM) is 2.361 AÊ
3 Daÿ1
with a solvent content of 47.9% by volume
(Matthews, 1968) when one unit cell was
assumed to contain eight molecules of
SEDL. This corresponds to one molecule of
SEDL per asymmetric unit. A search for
suitable heavy-atom derivative crystals is in
progress in parallel with an effort to obtain
crystals of selenomethionine-substituted
protein.
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